![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Huayi Pharmaceutical Co., Ltd. Yiwu Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Duloxetine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2015-155 - Rev 01
This Chemical Type CEP, issued on January 24, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2594 associated with this CEP further emphasizes